{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:16:41Z","timestamp":1790551001691,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T00:00:00Z","timestamp":1433548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T00:00:00Z","timestamp":1433548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA153170, and CA158692"],"award-info":[{"award-number":["CA153170, and CA158692"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK091490"],"award-info":[{"award-number":["DK091490"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13045-015-0161-1","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T07:50:30Z","timestamp":1433490630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Targeting Wnt pathway in mantle cell lymphoma-initiating cells"],"prefix":"10.1186","volume":"8","author":[{"given":"Rohit","family":"Mathur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank K.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Berkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Romaguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Alma","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattva S.","family":"Neelapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,6]]},"reference":[{"issue":"5","key":"161_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/00001622-200109000-00005","volume":"13","author":"JP Leonard","year":"2001","unstructured":"Leonard JP, Schattner EJ, Coleman M. Biology and management of mantle cell lymphoma. Curr Opin Oncol. 2001;13(5):342\u20137.","journal-title":"Curr Opin Oncol"},{"issue":"8","key":"161_CR2","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3109\/10428194.2012.656628","volume":"53","author":"R Chandran","year":"2012","unstructured":"Chandran R, Gardiner SK, Simon M, Spurgeon SE. Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007. Leuk Lymphoma. 2012;53(8):1488\u201393.","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"161_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/ajh.23615","volume":"88","author":"JM Vose","year":"2013","unstructured":"Vose JM. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management. Am J Hematol. 2013;88(12):1082\u20138.","journal-title":"Am J Hematol"},{"issue":"6","key":"161_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1517\/14656560902895715","volume":"10","author":"M Prichard","year":"2009","unstructured":"Prichard M, Harris T, Williams ME, Densmore JJ. Treatment strategies for relapsed and refractory aggressive non-Hodgkin\u2019s lymphoma. Expert Opin Pharmacother. 2009;10(6):983\u201395.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"161_CR5","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3109\/10428194.2013.825903","volume":"55","author":"F Zaja","year":"2013","unstructured":"Zaja F, Federico M, Vitolo U, Zinzani PL. Management of relapsed\/refractory mantle cell lymphoma: a review of current therapeutic strategies. Leuk Lymphoma. 2013;55(5):988\u201398.","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"161_CR6","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra061808","volume":"355","author":"CT Jordan","year":"2006","unstructured":"Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med. 2006;355(12):1253\u201361.","journal-title":"N Engl J Med"},{"issue":"6859","key":"161_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105\u201311.","journal-title":"Nature"},{"issue":"6464","key":"161_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367(6464):645\u20138.","journal-title":"Nature"},{"issue":"7","key":"161_CR9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730\u20137.","journal-title":"Nat Med"},{"issue":"3","key":"161_CR10","first-page":"179","volume":"101","author":"M Ratajczak","year":"2010","unstructured":"Ratajczak M, Tarnowski M, Staniszewska M, Sroczynski T, Banach B. Mechanisms of cancer metastasis: involvement of cancer stem cells? Minerva Med. 2010;101(3):179\u201391.","journal-title":"Minerva Med"},{"issue":"4","key":"161_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.2174\/092986709787315531","volume":"16","author":"R Besancon","year":"2009","unstructured":"Besancon R, Valsesia-Wittmann S, Puisieux A, Caron de Fromentel C, Maguer-Satta V. Cancer stem cells: the emerging challenge of drug targeting. Curr Med Chem. 2009;16(4):394\u2013416.","journal-title":"Curr Med Chem."},{"issue":"13","key":"161_CR12","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1182\/blood-2008-02-139212","volume":"112","author":"P Gelebart","year":"2008","unstructured":"Gelebart P, Anand M, Armanious H, Peters AC, Dien Bard J, Amin HM, et al. Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma. Blood. 2008;112(13):5171\u20139.","journal-title":"Blood"},{"issue":"2","key":"161_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3892\/ijo.2013.1982","volume":"43","author":"Y Kimura","year":"2013","unstructured":"Kimura Y, Arakawa F, Kiyasu J, Miyoshi H, Yoshida M, Ichikawa A, et al. The Wnt signaling pathway and mitotic regulators in the initiation and evolution of mantle cell lymphoma: gene expression analysis. Int J Oncol. 2013;43(2):457\u201368.","journal-title":"Int J Oncol"},{"issue":"4","key":"161_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","volume":"130","author":"EG Rizzatti","year":"2005","unstructured":"Rizzatti EG, Falcao RP, Panepucci RA, Proto-Siqueira R, Anselmo-Lima WT, Okamoto OK, et al. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. Br J Haematol. 2005;130(4):516\u201326.","journal-title":"Br J Haematol"},{"issue":"8","key":"161_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.semcdb.2010.09.004","volume":"21","author":"P Wend","year":"2010","unstructured":"Wend P, Holland JD, Ziebold U, Birchmeier W. Wnt signaling in stem and cancer stem cells. Semin Cell Dev Biol. 2010;21(8):855\u201363.","journal-title":"Semin Cell Dev Biol"},{"key":"161_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1756-8722-3-33","volume":"3","author":"X Ge","year":"2010","unstructured":"Ge X, Wang X. Role of Wnt canonical pathway in hematological malignancies. J Hematol Oncol. 2010;3:33.","journal-title":"J Hematol Oncol."},{"issue":"1","key":"161_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13(1):11\u201326.","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"161_CR18","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","volume":"16","author":"H Aberle","year":"1997","unstructured":"Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997;16(13):3797\u2013804.","journal-title":"EMBO J"},{"issue":"6592","key":"161_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/382638a0","volume":"382","author":"J Behrens","year":"1996","unstructured":"Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 1996;382(6592):638\u201342.","journal-title":"Nature"},{"issue":"5","key":"161_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a008052","volume":"4","author":"P Polakis","year":"2012","unstructured":"Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 2012;4(5):1\u201313.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"161_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","volume":"20","author":"CY Logan","year":"2004","unstructured":"Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781\u2013810.","journal-title":"Annu Rev Cell Dev Biol."},{"issue":"3","key":"161_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/jcp.2003.009506","volume":"58","author":"S Salahshor","year":"2005","unstructured":"Salahshor S, Woodgett JR. The links between axin and carcinogenesis. J Clin Pathol. 2005;58(3):225\u201336.","journal-title":"J Clin Pathol"},{"key":"161_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.genom.3.022502.103043","volume":"3","author":"WM Grady","year":"2002","unstructured":"Grady WM, Markowitz SD. Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet. 2002;3:101\u201328.","journal-title":"Annu Rev Genomics Hum Genet."},{"issue":"2","key":"161_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrclinonc.2010.196","volume":"8","author":"N Takebe","year":"2011","unstructured":"Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol. 2011;8(2):97\u2013106.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"161_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.scr.2010.07.003","volume":"5","author":"Z Chen","year":"2010","unstructured":"Chen Z, Ayala P, Wang M, Fayad L, Katz RL, Romaguera J, et al. Prospective isolation of clonogenic mantle cell lymphoma-initiating cells. Stem Cell Res. 2010;5(3):212\u201325.","journal-title":"Stem Cell Res"},{"issue":"4","key":"161_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091042","volume":"9","author":"DJ Medina","year":"2014","unstructured":"Medina DJ, Abass-Shereef J, Walton K, Goodell L, Aviv H, Strair RK, et al. Cobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells. PLoS One. 2014;9(4), e91042.","journal-title":"PLoS One"},{"issue":"6","key":"161_CR27","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3109\/10428194.2011.562570","volume":"52","author":"HJ Jung","year":"2011","unstructured":"Jung HJ, Chen Z, McCarty N. Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma. Leuk Lymphoma. 2011;52(6):1066\u201379.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"161_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1306220","volume":"369","author":"ML Wang","year":"2013","unstructured":"Wang ML, Rule S, Martin P, Goy A, Auer R, Kahl BS, et al. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med. 2013;369(6):507\u201316.","journal-title":"N Engl J Med"},{"issue":"72","key":"161_CR29","doi-asserted-by":"publisher","first-page":"ra25","DOI":"10.1126\/scisignal.2000230","volume":"2","author":"RG James","year":"2009","unstructured":"James RG, Biechele TL, Conrad WH, Camp ND, Fass DM, Major MB, et al. Bruton\u2019s tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling. Sci Signal. 2009;2(72):ra25.","journal-title":"Sci Signal"},{"issue":"5","key":"161_CR30","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jcb.22447","volume":"109","author":"RA Bhat","year":"2010","unstructured":"Bhat RA, Stauffer B, Della Pietra A, Bodine PV. Wnt3-frizzled 1 chimera as a model to study canonical Wnt signaling. J Cell Biochem. 2010;109(5):876\u201384.","journal-title":"J Cell Biochem"},{"issue":"2","key":"161_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/08977190500125746","volume":"23","author":"R Widelitz","year":"2005","unstructured":"Widelitz R. Wnt signaling through canonical and non-canonical pathways: recent progress. Growth Factors. 2005;23(2):111\u20136.","journal-title":"Growth Factors"},{"issue":"1\u20133","key":"161_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12026-009-8116-7","volume":"46","author":"K Kokolus","year":"2010","unstructured":"Kokolus K, Nemeth MJ. Non-canonical Wnt signaling pathways in hematopoiesis. Immunol Res. 2010;46(1\u20133):155\u201364.","journal-title":"Immunol Res"},{"issue":"15","key":"161_CR33","doi-asserted-by":"publisher","first-page":"14879","DOI":"10.1074\/jbc.M306421200","volume":"279","author":"T Golan","year":"2004","unstructured":"Golan T, Yaniv A, Bafico A, Liu G, Gazit A. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. J Biol Chem. 2004;279(15):14879\u201388.","journal-title":"J Biol Chem"},{"issue":"10","key":"161_CR34","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc2230","volume":"7","author":"P Jares","year":"2007","unstructured":"Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer. 2007;7(10):750\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"161_CR35","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0002-9440(10)65399-0","volume":"154","author":"JY Li","year":"1999","unstructured":"Li JY, Gaillard F, Moreau A, Harousseau JL, Laboisse C, Milpied N, et al. Detection of translocation t (11;14) (q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol. 1999;154(5):1449\u201352.","journal-title":"Am J Pathol"},{"issue":"13","key":"161_CR36","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","volume":"106","author":"K Fu","year":"2005","unstructured":"Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood. 2005;106(13):4315\u201321.","journal-title":"Blood"},{"issue":"12","key":"161_CR37","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","volume":"111","author":"I Wlodarska","year":"2008","unstructured":"Wlodarska I, Dierickx D, Vanhentenrijk V, Van Roosbroeck K, Pospisilova H, Minnei F, et al. Translocations targeting CCND2, CCND3, and MYCN do occur in t (11;14)-negative mantle cell lymphomas. Blood. 2008;111(12):5683\u201390.","journal-title":"Blood"},{"issue":"16","key":"161_CR38","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1182\/blood-2010-02-269878","volume":"116","author":"A Gutierrez Jr","year":"2010","unstructured":"Gutierrez Jr A, Tschumper RC, Wu X, Shanafelt TD, Eckel-Passow J, Huddleston 3rd PM, et al. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood. 2010;116(16):2975\u201383.","journal-title":"Blood"},{"issue":"2","key":"161_CR39","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.lungcan.2011.10.007","volume":"76","author":"N Nakashima","year":"2012","unstructured":"Nakashima N, Liu D, Huang CL, Ueno M, Zhang X, Yokomise H. Wnt3 gene expression promotes tumor progression in non-small cell lung cancer. Lung Cancer. 2012;76(2):228\u201334.","journal-title":"Lung Cancer"},{"issue":"5","key":"161_CR40","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/sj.leu.2404132","volume":"20","author":"J Ratajczak","year":"2006","unstructured":"Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006;20(5):847\u201356.","journal-title":"Leukemia"},{"issue":"20","key":"161_CR41","doi-asserted-by":"publisher","first-page":"8149","DOI":"10.1158\/0008-5472.CAN-10-0315","volume":"70","author":"AM Cole","year":"2010","unstructured":"Cole AM, Myant K, Reed KR, Ridgway RA, Athineos D, Van den Brink GR, et al. Cyclin D2-cyclin-dependent kinase 4\/6 is required for efficient proliferation and tumorigenesis following Apc loss. Cancer Res. 2010;70(20):8149\u201358.","journal-title":"Cancer Res"},{"issue":"15","key":"161_CR42","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1073\/pnas.0701509104","volume":"104","author":"IC Rulifson","year":"2007","unstructured":"Rulifson IC, Karnik SK, Heiser PW, ten Berge D, Chen H, Gu X, et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci U S A. 2007;104(15):6247\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"161_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ccr.2004.09.032","volume":"6","author":"A Bafico","year":"2004","unstructured":"Bafico A, Liu G, Goldin L, Harris V, Aaronson SA. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004;6(5):497\u2013506.","journal-title":"Cancer Cell"},{"key":"161_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22146","author":"I Koneczny","year":"2014","unstructured":"Koneczny I, Schulenburg A, Hudec X, Knofler M, Holzmann K, Piazza G, et al. Autocrine fibroblast growth factor 18 signaling mediates Wnt-dependent stimulation of CD44-positive human colorectal adenoma cells. Molecular Carcinogenesis. 2014. doi:10.1002\/mc.22146.","journal-title":"Molecular Carcinogenesis"},{"issue":"1","key":"161_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canlet.2012.03.039","volume":"323","author":"H Zhang","year":"2012","unstructured":"Zhang H, Zhang X, Wu X, Li W, Su P, Cheng H, et al. Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt\/beta-catenin pathway. Cancer Lett. 2012;323(1):106\u201313.","journal-title":"Cancer Lett"},{"issue":"23","key":"161_CR46","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1038\/onc.2009.80","volume":"28","author":"M Flahaut","year":"2009","unstructured":"Flahaut M, Meier R, Coulon A, Nardou KA, Niggli FK, Martinet D, et al. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt\/beta-catenin pathway. Oncogene. 2009;28(23):2245\u201356.","journal-title":"Oncogene"},{"issue":"44","key":"161_CR47","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1038\/sj.onc.1202985","volume":"18","author":"A Gazit","year":"1999","unstructured":"Gazit A, Yaniv A, Bafico A, Pramila T, Igarashi M, Kitajewski J, et al. Human frizzled 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response. Oncogene. 1999;18(44):5959\u201366.","journal-title":"Oncogene"},{"issue":"11","key":"161_CR48","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1096\/fj.10-160994","volume":"24","author":"J Neumann","year":"2010","unstructured":"Neumann J, Schaale K, Farhat K, Endermann T, Ulmer AJ, Ehlers S, et al. Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages. FASEB J. 2010;24(11):4599\u2013612.","journal-title":"FASEB J"},{"issue":"17","key":"161_CR49","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1101\/gad.1686208","volume":"22","author":"T Grigoryan","year":"2008","unstructured":"Grigoryan T, Wend P, Klaus A, Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev. 2008;22(17):2308\u201341.","journal-title":"Genes Dev"},{"issue":"5","key":"161_CR50","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.bone.2007.01.005","volume":"40","author":"AC Andrade","year":"2007","unstructured":"Andrade AC, Nilsson O, Barnes KM, Baron J. Wnt gene expression in the post-natal growth plate: regulation with chondrocyte differentiation. Bone. 2007;40(5):1361\u20139.","journal-title":"Bone"},{"issue":"5","key":"161_CR51","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.cellsig.2013.02.006","volume":"25","author":"G Wan","year":"2013","unstructured":"Wan G, Mathur R, Hu X, Liu Y, Zhang X, Peng G, et al. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal. 2013;25(5):1086\u201395.","journal-title":"Cell Signal"},{"key":"161_CR52","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1038\/leu.2014.126","volume":"28","author":"L Sehgal","year":"2014","unstructured":"Sehgal L, Mathur R, Braun FK, Wise JF, Berkova Z, Neelapu S, et al. FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma. Leukemia. 2014;28:2376\u201387.","journal-title":"Leukemia."},{"issue":"8","key":"161_CR53","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3324\/haematol.2011.040659","volume":"97","author":"DJ Medina","year":"2012","unstructured":"Medina DJ, Goodell L, Glod J, Gelinas C, Rabson AB, Strair RK. Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor kappaB pathways. Haematologica. 2012;97(8):1255\u201363.","journal-title":"Haematologica"},{"issue":"3","key":"161_CR54","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2174\/156800911794519761","volume":"11","author":"R Mathur","year":"2011","unstructured":"Mathur R, Chandna S, Kapoor PN, Dwarakanath BS. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide. Cur Cancer Drug Targets. 2011;11(3):380\u201392.","journal-title":"Cur Cancer Drug Targets"},{"issue":"8","key":"161_CR55","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.embor.embor896","volume":"4","author":"J Jacob","year":"2003","unstructured":"Jacob J, Briscoe J. Gli proteins and the control of spinal-cord patterning. EMBO Rep. 2003;4(8):761\u20135.","journal-title":"EMBO Rep"},{"issue":"22","key":"161_CR56","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1101\/gad.243402","volume":"16","author":"M Persson","year":"2002","unstructured":"Persson M, Stamataki D, te Welscher P, Andersson E, Bose J, Ruther U, et al. Dorsal-ventral patterning of the spinal cord requires Gli3 transcriptional repressor activity. Genes Dev. 2002;16(22):2865\u201378.","journal-title":"Genes Dev"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-015-0161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13045-015-0161-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-015-0161-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-015-0161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T10:43:26Z","timestamp":1717929806000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-015-0161-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,6]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1186\/s13045-015-0161-1","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,6]]},"assertion":[{"value":"16 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"63"}}